Drug
Mrna 1010
Mrna 1010: highest development phase Post-Market, developed by ModernaTX, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- ModernaTX, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| mRNA-1010 NCT07884175 | Post-Market | Seasonal Influenza |
Latest
No recent events.
Follow Mrna 1010 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.